These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 5540546)

  • 21. Hypercalcitoninemia, hypocalcemia, and toxic shock syndrome.
    Sperber SJ; Blevins DD; Francis JB
    Rev Infect Dis; 1990; 12(5):736-9. PubMed ID: 2237110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].
    Galán Galán F; Garrido Peralta M
    Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936
    [No Abstract]   [Full Text] [Related]  

  • 23. Combining provocative agents of calcitonin to detect medullary carcinoma of the thyroid.
    Sisson JC; Gross MD; Frietas JE; Jackson CE; England BG
    Henry Ford Hosp Med J; 1981; 29(2):75-80. PubMed ID: 7263287
    [No Abstract]   [Full Text] [Related]  

  • 24. Somatostatin receptor expression in vivo and response to somatostatin analog therapy with or without other antineoplastic treatments in advanced medullary thyroid carcinoma.
    Vainas I; Koussis Ch; Pazaitou-Panayiotou K; Drimonitis A; Chrisoulidou A; Iakovou I; Boudina M; Kaprara A; Maladaki A
    J Exp Clin Cancer Res; 2004 Dec; 23(4):549-59. PubMed ID: 15743023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
    Dorairajan N; Siddharth D; Kanna S
    Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent hypercalcitoninemia in patients with medullary thyroid cancer: a therapeutic approach based on selective venous sampling for calcitonin.
    Medina-Franco H; Herrera MF; López G; Tielve-Campillo M; Sierra M; Lozano-Salazar RR; González O
    Rev Invest Clin; 2001; 53(3):212-7. PubMed ID: 11496707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistology, light microscopy, and ultrastructural morphology of transplantable rat medullary thyroid carcinomas.
    McMillan PJ; Thaete LG; Hooker WM; Roos BA
    Cancer Res; 1980 May; 40(5):1419-26. PubMed ID: 7370980
    [No Abstract]   [Full Text] [Related]  

  • 28. [Transient hypocalcemia after thyroidectomy].
    Di Paola S; Pagano G; Persico Stella L; Di Domenica M; Napoleoni A; Caporossi M; Carones S
    Minerva Endocrinol; 1996 Jun; 21(2):79-82. PubMed ID: 9026685
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcitonin measurement to detect medullary thyroid carcinoma in nodular goiter: German evidence-based consensus recommendation.
    Karges W; Dralle H; Raue F; Mann K; Reiners C; Grussendorf M; Hüfner M; Niederle B; Brabant G;
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):52-8. PubMed ID: 14758572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of the major forms of human calcitonin in tissue and serum.
    Dermody WC; Rosen MA; Ananthaswamy R; McCormick WM; Levy AG
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1090-8. PubMed ID: 7228999
    [No Abstract]   [Full Text] [Related]  

  • 31. Hypocalcemia and an inappropriate endocrine response in osteoblastic metastatic breast cancer.
    Bouvier DP
    South Med J; 1989 Dec; 82(12):1574-6. PubMed ID: 2556799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocalcemia--an unusual metabolic complication of breast cancer.
    Hall TC; Griffiths CT; Petranek JR
    N Engl J Med; 1966 Dec; 275(26):1474-7. PubMed ID: 5956375
    [No Abstract]   [Full Text] [Related]  

  • 33. Medullary carcinoma of the thyroid with hypocalcemia and diarrhea.
    Am J Med; 1969 Jun; 46(6):961-71. PubMed ID: 5802435
    [No Abstract]   [Full Text] [Related]  

  • 34. [Epithelioma of the thyroid secreting thyrocalcitonin].
    Milhaud G; Tubiana M; Parmentier C; Coutris G
    C R Acad Hebd Seances Acad Sci D; 1968 Feb; 266(6):608-10. PubMed ID: 4969171
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunofluorescent localisation of calcitonin in medullary C-cell thyroid carcinoma, using antibody to the pure porcine hormone.
    Bussolati G; Foster GV; Clark MB; Pearse AG
    Virchows Arch B Cell Pathol; 1969; 2(3):234-8. PubMed ID: 4978695
    [No Abstract]   [Full Text] [Related]  

  • 36. Bone remodeling during calcitonin excess: reconstruction of the remodeling sequence in medullary thyroid carcinoma.
    Eriksen EF; Kudsk H; Emmertsen K; Mosekilde L; Melsen F
    Bone; 1993; 14(3):399-401. PubMed ID: 8363884
    [No Abstract]   [Full Text] [Related]  

  • 37. Measurement of thyrocalcitonin-like activity in urine of patients with medullary carcinoma.
    Voelkel EF; Tashjian AH
    J Clin Endocrinol Metab; 1971 Jan; 32(1):102-9. PubMed ID: 5539023
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypocalcemia resulting from calcium accretion by a chondrosarcoma.
    Relkin R
    Cancer; 1974 Nov; 34(5):1834-7. PubMed ID: 4426040
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypercalcitoninemia in pancreatitis--evidence for immunochemical heterogeneity.
    Cannarozzi DB; Donabedian RK
    Experientia; 1977 Apr; 33(4):543-4. PubMed ID: 862767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A case of impetigo herpetiformis with hypercalcitoninemia.
    Nitta Y; Yasue T
    J Dermatol; 1985 Dec; 12(6):526-9. PubMed ID: 3913690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.